Cargando…
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
Endoxifen, an active metabolite of tamoxifen, has been shown to be an effective anti-estrogenic agent in estrogen receptor-positive breast cancer patients. In melanoma, estrogen receptor expression is shown to be associated with disease progression. However, the therapeutic benefit of endoxifen in m...
Autores principales: | Chen, Paul, Sheikh, Saifuddin, Ahmad, Ateeq, Ali, Shoukath M., Ahmad, Moghis U., Ahmad, Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751858/ https://www.ncbi.nlm.nih.gov/pubmed/29308069 http://dx.doi.org/10.1186/s11658-017-0068-7 |
Ejemplares similares
-
Carbohydrate mediated drug delivery: Synthesis and characterization of new lipid-conjugates
por: Ahmad, Moghis U., et al.
Publicado: (2015) -
Endoxifen, a New Treatment Option for Mania: A Double‐Blind, Active‐Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen
por: Ahmad, A, et al.
Publicado: (2016) -
Learned-SBL-GAMP based hybrid precoders/combiners in millimeter wave massive MIMO systems
por: Ali K., Shoukath, et al.
Publicado: (2023) -
Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
por: Nikoulina, Svetlana E, et al.
Publicado: (2012) -
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
por: Dezentjé, V. O., et al.
Publicado: (2015)